MoonLake Immunotherapeutics

NASDAQ:MLTX

Biotechnology

Healthcare
$11.25 +0.69%

+$0.13 today

Market cap
$957.45M
Beta
1.04
P/E (TTM)
-5.4
EPS (TTM)
-$3.61
52W Low $5.95High $62.75

Volume 1.17M

Average 0.99M

Price history

MoonLake Immunotherapeutics SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-16.04%

Period high

$22.16

Period low

$9.55

Latest

$11.25

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 4, 2026Nov 4, 2026
10-QNov 4, 2026Nov 4, 2026
8-KSep 30, 2026Sep 30, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
S-3ASRAug 10, 2026Aug 10, 2026
S-8Aug 10, 2026Aug 10, 2026
10-QAug 10, 2026Aug 10, 2026
8-KAug 10, 2026Aug 10, 2026
4Jul 29, 2026Jul 29, 2026
4Jul 23, 2026Jul 23, 2026
4Jul 21, 2026Jul 21, 2026
4Jul 20, 2026Jul 20, 2026
8-KJul 15, 2026Jul 14, 2026

Competitors

Who does MoonLake Immunotherapeutics compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about MLTX's filings, answered from its disclosures.

What is the latest MLTX filing?

The latest filing shown is 8-K dated Nov 4, 2026.

How many recent filings does MLTX have?

Intrinsic Alpha currently shows 20 recent filings for MLTX.